Dysbiosis in benign and malignant diseases of the exocrine pancreas

Robert Memba, Sinead N. Duggan, Rosa Jorba, Kevin C. Conlon

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

The consequences of dysbiosis in pancreatic diseases remain unclear, with a limited body of evidence suggesting that there may be an association between dysbiosis and pancreatic disease; however, some of the studies show contradictory results. Regarding acute and chronic pancreatitis, data are scarce, but dysbiosis appears to be present in both conditions. Some studies show lower levels of Bifidobacterium or Lactobacillus and higher levels of Enterobacteriaceae in chronic pancreatitis. One study shows higher levels of Enterococcus and lower levels of Bifidobacterium in acute pancreatitis. There is stronger evidence of a link between microbiota imbalance and pancreatic cancer. There is an overall association between pancreatic cancer and lower levels of Neisseria elongate and Streptococcus mitis and higher levels of Porphyromonas gingivalis and Granulicatella adiacens. However, further investigation is required to confirm these findings, and to explore clinical implications such as screening and therapeutic possibilities.

Original languageEnglish
Title of host publicationMicrobiome and metabolome in diagnosis, therapy, and other strategic applications
EditorsJoel Faintuch, Salomao Faintuch
PublisherAcademic Press Inc.
Chapter37
Pages357-364
ISBN (Print)9780128152492
DOIs
Publication statusPublished - 15 Feb 2019
Externally publishedYes

Fingerprint

Dive into the research topics of 'Dysbiosis in benign and malignant diseases of the exocrine pancreas'. Together they form a unique fingerprint.

Cite this